Effect of Prone Positioning Combined With High Flow Oxygen Therapy on Oxygenation During Acute Respiratory Failure Due to COVID-19
NCT ID: NCT04543760
Last Updated: 2022-03-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
18 participants
INTERVENTIONAL
2020-10-01
2021-03-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Prone positioning (PP) is a recommended strategy for patients with moderate to severe acute respiratory distress syndrome (ARDS) undergoing invasive mechanical ventilation.
Early PP combined with High Flow Oxygen Therapy may benefit spontaneous breathing patients with AHRF due to COVID-19 as recently reported in Jiangsu.
Our hypothesis is that early PP combined with High Flow Oxygen Therapy in patients with AHRF due to COVID-19 improves oxygenation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prone Positioning and High-flow Nasal Cannula in COVID-19 Induced ARDS
NCT04391140
Prone Positioning in COVID-19 Patients
NCT05150847
A Physiological Study to Assess Awake Prone Positioning and Respiratory Support in Healthy Volunteers
NCT05512585
Hemodynamic Effect of Prone Position in Non-intubated Patient With COVID 19
NCT04834947
Extended Prone Position Duration COVID-19-related ARDS: a Retrospective Study
NCT05124197
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
[PP sequence 1] - Wash-out - [SP sequence 2]
Prone position
prone positioning in spontaneous ventilation
Supine position
supine positiong in spontaneous ventilation
[SP sequence 1] - Wash-out - [PP sequence 2]
Prone position
prone positioning in spontaneous ventilation
Supine position
supine positiong in spontaneous ventilation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Prone position
prone positioning in spontaneous ventilation
Supine position
supine positiong in spontaneous ventilation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admitted to ICU within 72 hours,
* Having confirmed or highly suspected COVID-19 infection (positive RT-PCR and/or computed tomography),
* Having acute hypoxemic respiratory failure with a \[PaO2/FiO2\] ratio between 100 mmHg and 300 mmHg,
* Having given free and informed written consent,
* Being affiliated with or benefiting from a social security scheme.
Exclusion Criteria
* Unable to achieve a prone position due to agitation whatever the cause,
* With clinical occlusive syndrome in order to limit the risk of inhalation,
* Having a contraindication to the use of the esophageal catheter,
* Having signs of respiratory distress or disturbance of consciousness requiring intubation within the next hours,
* Having hypercapnia indicating the use of non-invasive ventilation (PaO2\> 50 mmHg),
* Having severe hypoxemia defined by PaO2 / FiO2 \<100mmHg,
* Ongoing pregnancy or breastfeeding,
* Subject to a measure for the protection of justice.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital St. Joseph, Marseille, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Samuel LEHINGUE, M.D
Role: PRINCIPAL_INVESTIGATOR
Hopital Saint Joseph Marseille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital Européen
Marseille, , France
Hopital La Timone
Marseille, , France
Hopital Saint Joseph
Marseille, , France
Hopital Nord
Marseille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-04-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.